ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,265Medicare Part D Prescriptions Filled, Including Refills

Rank: 350 out of 2170

$618K Total Retail Price of All Prescriptions

Rank: 294 out of 2170

287 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 287 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 287 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 7,581 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
AMLODIPINE BESYLATE 448 394 1 4
SIMVASTATIN 446 367 2 1
OMEPRAZOLE 335 263 3 2
FUROSEMIDE 332 289 4 6
CRESTOR 284 212 5 24
LISINOPRIL 263 208 6 3
HYDROCODONE-ACETAMINOPHEN 245 141 S3 7 7
METOPROLOL TARTRATE 241 214 8 10
MELOXICAM 222 194 9 28
METFORMIN HCL 207 159 10 8
ATORVASTATIN CALCIUM 198 143 11 12
CITALOPRAM HBR 186 140 12 19
LEVOTHYROXINE SODIUM 178 149 13 5
NEXIUM 172 120 14 22
GABAPENTIN 169 92 15 14
METOPROLOL SUCCINATE 161 115 16 13
AMLODIPINE BESYLATE-BENAZEPRIL 153 111 17 67
HYDROCHLOROTHIAZIDE 138 109 18 9
PRAVASTATIN SODIUM 135 114 19 11
PANTOPRAZOLE SODIUM 133 112 20 39
CYMBALTA 116 37 21 44
DIOVAN 105 103 22 53
CLOPIDOGREL 101 83 23 37
FLUOXETINE HCL 100 62 24 59
POTASSIUM CHLORIDE 99 54 25 16
ZOLPIDEM TARTRATE 96 62 26 17
CELEBREX 95 84 27 89
DIOVAN HCT 92 73 28 76
LISINOPRIL-HYDROCHLOROTHIAZIDE 90 77 29 20
GLIMEPIRIDE 89 47 30 31
WARFARIN SODIUM 84 49 31 15
PLAVIX 76 61 32 58
ALENDRONATE SODIUM 75 66 33 36
NAMENDA 73 73 34 48
KLOR-CON M20 72 49 35 68
SYNTHROID 71 53 36 27
ISOSORBIDE MONONITRATE ER 68 63 37 50
SERTRALINE HCL 68 67 37 25
TRAMADOL HCL 59 52 39 18
ESCITALOPRAM OXALATE 58 43 40 75
PROMETHAZINE HCL 57 23 R 41 70
DONEPEZIL HCL 56 56 42 32
SPIRIVA 56 36 42 49
CARVEDILOL 55 50 44 26
CYCLOBENZAPRINE HCL 54 24 R 45 52
NAPROXEN 53 28 46 107
ACTOS 53 48 46 108
DILTIAZEM ER 52 52 48 133
COLCRYS 50 50 49 140
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 21, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.